Celularity Inc. (NASDAQ: CELU)
$3.08
-0.1100 ( -3.45% ) 13.5K
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases.
Market Data
Open
$3.08
Previous close
$3.19
Volume
13.5K
Market cap
$67.09M
Day range
$3.00 - $3.28
52 week range
$1.59 - $7.97
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | May 24, 2024 |
8-k | 8K-related | 74 | May 21, 2024 |
nt | Quarterly Reports | 1 | May 15, 2024 |
8-k | 8K-related | 14 | Apr 22, 2024 |
4 | Insider transactions | 1 | Apr 16, 2024 |
4 | Insider transactions | 1 | Apr 16, 2024 |
4 | Insider transactions | 1 | Apr 16, 2024 |
4 | Insider transactions | 1 | Apr 16, 2024 |
4 | Insider transactions | 1 | Apr 16, 2024 |
nt | Quarterly Reports | 1 | Apr 01, 2024 |